홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tryptamine → 1-Indan-5-yl-2,3,4,9-tetrahydro-1H-beta-carboline

HRID 381473
인쇄

반응식

HRID 381473 반응식
[NH2:1][CH2:2][CH2:3][C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[NH:6][CH:5]=1.[CH2:13]1[C:21]2[C:16](=[CH:17][C:18]([CH:22]=O)=[CH:19][CH:20]=2)[CH2:15][CH2:14]1.C(O)(C(F)(F)F)=O>>[CH2:13]1[C:21]2[C:16](=[CH:17][C:18]([CH:22]3[C:5]4[NH:6][C:7]5[C:12](=[CH:11][CH:10]=[CH:9][CH:8]=5)[C:4]=4[CH2:3][CH2:2][NH:1]3)=[CH:19][CH:20]=2)[CH2:15][CH2:14]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 1150TryptamineHCID 6422Trifluoroacetic acidHCID 1216245-Indanecarboxaldehyde

생성물 1

HCID 108807391-Indan-5-yl-2,3,4,9-tetrahydro-1H-beta-carboline수율 15.6%

실험 절차

This product was prepared using the same procedure as for Intermediate 1 with tryptamine (1.28 g, 8.0 mmol), indan-5-carboxaldehyde (1.3 g, 1.1 equiv.) and TFA (1.2 mL, 2 equiv.) to give the title compound (0.36 g, 14%).

후처리

  1. customThis product was prepared

출처 및 근거

ORD 기록
ord-407958afdb2346f3baf4dbeda805a3ed
출처 데이터셋
uspto-grants-2001_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06306870B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트